Company Actelion CBOE EUROPE EQUITIES
Equities
ATLN
CH0010532478
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- CHF | - |
2017 | Actelion : France's Sanofi raises earnings forecast, pleased with eczema drug uptake | RE |
2017 | Johnson & Johnson : J&J sees sales growth in near-term; raises 2017 profit forecast | RE |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 107,329,410 | 2,009,425 ( 1.872 %) | 4,654,225 ( 4.336 %) | 1.872 % |
Company contact information
Actelion Ltd.
Gewerbestrasse 16
4123, Allschwil
+
Sector
1st Jan change | Capi. | |
---|---|---|
+17.73% | 124B | |
+16.88% | 111B | |
-9.04% | 23.17B | |
+5.50% | 22.94B | |
-38.15% | 17.42B | |
-7.75% | 17.42B | |
-14.99% | 16.9B | |
+3.42% | 13.71B | |
+29.63% | 11.82B |
- Stock Market
- Equities
- ATLN Stock
- ATLN Stock
- Company Actelion